# Vir Biotechnology, Inc.: Form 8-K, filed Feb 26, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-02-26
- Accepted by EDGAR: Feb 26, 2026, 17:20 ET
- Period: 2026-02-25
- Accession: 0001193125-26-077416
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000119312526077416/d85338d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000119312526077416/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000119312526077416/d85338d8k.htm

Filed Feb 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-077416. Last ingested by Listed: Nov 10, 2026, 17:35 ET. No prices; not investment advice.